Istituto Oncologico Veneto - I.R.C.C.S.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Liver and biliary tract cancer1 trial
• Melanoma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Jazz Pharmaceuticals1 trial
• Pfizer1 trial

Closed trials

• Completed

  A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers

  NCT04466891· Phase 2· Jazz Pharmaceuticals· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· Phase 3· Pfizer· Source